Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages 1905-1912

  Yip, Linwah ^a   Farris, Coreen ^a   Kabaker, Adam S ^a   Hodak, Steven P ^a   Nikiforova, Marina N ^a   McCoy, Kelly L ^a   Stang, Michael T ^a   Smith, Kenneth J ^a   Nikiforov, Yuri E ^a   Carty, Sally E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASPIRATION BIOPSY; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC TEST; HEALTH CARE COST; HEALTH CARE UTILIZATION; HISTOLOGY; HUMAN; LOBECTOMY; MAJOR CLINICAL STUDY; MOLECULAR TESTING; ONCOCYTOMA; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROID NODULE; THYROIDECTOMY;

ADENOMA, OXYPHILIC; ALGORITHMS; BIOPSY, FINE-NEEDLE; COST-BENEFIT ANALYSIS; DECISION TREES; GENETIC TESTING; HUMANS; PREOPERATIVE CARE; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; UNNECESSARY PROCEDURES;

EID: 84861977027     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3048     Document Type: Article

References (37)

1. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
2. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds) 2010 SEER Cancer Statistics Review, 1975-2007. http://seer.cancer.gov/csr/1975-2007/. Bethesda, MD: National Cancer Institute
3. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer; Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
4. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P 2010 AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest 33(5 Suppl):51-56
5. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ 2008 Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol 36:425-437
6. Nikiforova MN, Nikiforov YE 2009 Molecular diagnostics and predictors in thyroid cancer. Thyroid 19:1351-1361
7. Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E 2010 Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg 34:2589-2594
8. Cantara S, Capezzone M, Marchisotta S, Capuano S, Busonero G, Toti P, Di Santo A, Caruso G, Carli AF, Brilli L, Montanaro A, Pacini F 2010 Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 95:1365-1369
9. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098
10. Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN 2011 Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96:3390-3397
11. Yip L, Nikiforova MN, Carty SE, Yim JH, Stang MT, Tublin MJ, Lebeau SO, Hodak SP, Ogilvie JB, Nikiforov YE 2009 Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation. Surgery 146:1215-1223
12. O'Neill CJ, Bullock M, Chou A, Sidhu SB, Delbridge LW, Robinson BG, Gill AJ, Learoyd DL, Clifton-Bligh R, Sywak MS 2010 BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery 148:1139-1145; discussion 1145-1146
13. Arias E 2010 United States life tables, 2006. Natl Vital Stat Rep 58:1-40
14. Faquin WC, Baloch ZW 2010 Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol 38:731-739
15. Nayar R, Ivanovic M 2009 The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer 117:195-202
16. Cibas ES, Ali SZ; NCI Thyroid FNA 2009 State of the Science Conference. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 132:658-665
17. Theoharis CG, Schofield KM, Hammers L, Udelsman R, Chhieng DC 2009 The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 19:1215-1223
18. Jo VY, Stelow EB, Dustin SM, Hanley KZ 2010 Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 134:450-456
19. Yang J, Schnadig V, Logrono R, Wasserman PG 2007 Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 111:306-315
20. Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore Jr FD, Kim BW, Nosé V, Marqusee E, Larsen PR, Alexander EK 2007 Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 111:508-516 (Pubitemid 350304903)
21. Asari R, Niederle BE, Scheuba C, Riss P, Koperek O, Kaserer K, Niederle B 2010 Indeterminate thyroid nodules: a challenge for the surgical strategy. Surgery 148:516-525
22. Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, Pelizzo MR, Pezzullo L 2004 Complications of thyroid surgery: analysis of multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 28:271-276 (Pubitemid 38375527)
23. Stoll SJ, Pitt SC, Liu J, Schaefer S, Sippel RS, Chen H 2009 Thyroid hormone replacement after thyroid lobectomy. Surgery 146:554-558; discussion 558-560
24. McHenry CR, Slusarczyk SJ 2000 Hypothyroidism following hyemithyroidectomy: incidence, risk factors, and management. Surgery 128:994-998
25. Agency for Healthcare and Research Quality, US Department of Health and Human Services 2010 Welcome to HCUPnet (Healthcare Cost and Utilization Project). http://hcupnet.ahrq.gov/. Accessed December 2010
26. McHenry CR 1997 "Same-day" thyroid surgery: an analysis of safety, cost savings, and outcome. Am Surg 63:586-589; discussion 589-590
27. Mowschenson PM, Hodin RA 1995 Outpatient thyroid and parathyroid surgery: a prospective study of feasibility, safety and costs. Surgery 118:1051-1053; discussion 1053-1054
28. Tuggle CT, Roman S, Udelsman R, Sosa JA 2011 Same-day thyroidectomy: a review of practice patterns and outcomes for 1,168 procedures in New York state. Ann Surg Oncol 18:1035-1040
29. Centers for Medicare and Medicaid Services, US Department of Health and Human Services 2010 Physician Fee Schedule Search. http://www.cms.gov/apps/ physician-fee-schedule/ (accessed December 2010)
30. Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R 1998 The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320-330 (Pubitemid 30191695)
31. Vidal-Trecan GM, Stahl JE, Durand-Zaleski I 2002 Managing toxic thyroid adenoma: a cost-effectiveness analysis. Eur J Endocrinol 146:283-294 (Pubitemid 34257637)
32. Gold MR 1996 Cost-effectiveness in health and medicine. New York: Oxford University Press
33. Shah MD, Witterick IJ, Eski SJ, Pinto R, Freeman JL 2006 Quality of life in patients undergoing thyroid surgery. J Otolaryngol 35:209-215 (Pubitemid 44368887)
34. Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE 2010 Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance." Cancer Cytopathol 118:17-23
35. Li H, Robinson KA, Anton B, Saldanha IJ, Ladenson PW 2011 Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab 96:E1719-E1726
36. Melck AL, Yip L, Carty SE 2010 The utility of BRAF testing in the management of papillary thyroid cancer. Oncologist 15:1285-1293
37. Shrime MG, Goldstein DP, Seaberg RM, Sawka AM, Rotstein L, Freeman JL, Gullane PJ 2007 Cost-effective management of lowrisk papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 133:1245-1253 (Pubitemid 350294254)